Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWise Group Regulatory News (WISE)

Share Price Information for Wise Group (WISE)

Share Price is delayed by 15 minutes
Get Live Data
786.00    0.00 (0.00%)
Bid:
720.00
Ask:
0.00
Spread: 70.00 (9.722%)
Market Cap: £7.86b
WISE Live PriceLast checked at - London Stock Exchange

Intraday Wise Group Share Chart

Wise plc American Depositary Receipt Program

18 Aug 2021 14:00

RNS Number : 0696J
Wise PLC
18 August 2021
 

Wise plc

18 August 2021

 

Wise plc American Depositary Receipt Program

 

Wise plc (LON: WISE) is pleased to announce it has taken steps today to establish a level 1 American Depositary Receipt (ADR) program in the US by filing a registration statement on Form F-6 with the US Securities and Exchange Commission. It is expected that Wise's ADRs will begin trading on the over-the-counter (OTC) market on 8 September 2021, under a ticker symbol that will be announced closer to the program's effective date.

The ADR program will complement Wise's existing primary listing on the London Stock Exchange. One Wise ADR will represent one underlying Wise class A ordinary share.

The ADR program does not involve the issuance of new shares or the raising of new capital by Wise.

ADRs allow US investors to buy shares in foreign companies without the need for cross-border or cross-currency transactions. They are priced in US dollars and can be traded like shares of US-based companies listed on the OTC market.

J.P. Morgan has been appointed as the depositary bank for the Level 1 ADR program. 

 

Further information

 

For further information on this update or the Company generally, please visit our website at www.wise.com/owners or see full contact details at the end of this release.

A copy of this announcement is available from the Company's website at www.wise.com/owners.

The Board of Directors of Wise authorised this announcement to be given to the London Stock Exchange.

 

Enquiries

 

Martin Adams - Head of Owner Relations

martin.adams@wise.com

Abigail Daniels - Head of Public Relations

press@wise.com

 

Brunswick Group 

Charles Pretzlik / Sarah West / Samantha Chiene 

Wise@brunswickgroup.com 

+44 (0) 20 7404 5959

 

About Wise

 

Wise is a global technology company, building the best way to move money around the world. With the Wise account people and businesses can hold 56 currencies, move money between countries and spend money abroad. Large companies and banks use Wise technology too; an entirely new cross-border payments network that will one day power money without borders for everyone, everywhere. However you use the platform, Wise is on a mission to make your life easier and save you money.

 

Co-founded by Kristo Käärmann and Taavet Hinrikus, Wise launched in 2011 under its original name TransferWise. It is one of the world's fastest growing, profitable tech companies and is listed on the London Stock Exchange under the ticker, WISE.

 

10 million people and businesses use Wise, which processes over £5 billion in cross-border transactions every month, saving customers over £1 billion a year.

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKFBDBBKDNFD
Date   Source Headline
9th Sep 20227:00 amRNSHolding(s) in Company
8th Sep 20227:00 amRNSTotal Voting Rights
6th Sep 20229:41 amRNSPDMR Shareholding
31st Aug 202211:31 amRNSTotal Voting Rights
15th Aug 202211:00 amRNSNotice of AGM
4th Aug 202212:01 pmRNSDirector/PDMR Shareholding
1st Aug 20224:50 pmRNSHolding(s) in Company
1st Aug 202210:02 amRNSTotal Voting Rights
25th Jul 202210:39 amRNSPDMR Shareholding
20th Jul 20222:12 pmRNSHolding(s) in Company
20th Jul 202211:43 amRNSPDMR Shareholding
19th Jul 20227:00 amRNSWise Plc Q1 FY23 Trading Update
6th Jul 20221:00 pmRNS2022 Annual Report & notice Q1 FY23 trading update
1st Jul 20223:57 pmRNSTotal Voting Rights
28th Jun 20227:00 amRNSWise plc FY22 results for year ended 31 March 2022
27th Jun 20227:00 amRNSFCA Investigation
31st May 20224:25 pmRNSTotal Voting Rights
25th May 20222:11 pmRNSDirector/PDMR Shareholding
17th May 20221:57 pmRNSCFO Update
6th May 20223:46 pmRNSQ1 2022 Mission Update
5th May 202212:46 pmRNSDirector/PDMR Shareholding
20th Apr 20223:12 pmRNSDirector/PDMR Shareholding
20th Apr 20223:11 pmRNSDirector/PDMR Shareholding
5th Apr 202212:19 pmRNSDirector/PDMR Shareholding
1st Apr 20229:00 amRNSChange of Remuneration Committee Chair
18th Mar 202211:51 amRNSChanges to Committee Composition
24th Feb 20223:54 pmRNSAppointment of Interim CFO
24th Feb 20223:02 pmRNSDirectorate Change
2nd Feb 20221:21 pmRNSDirector/PDMR Shareholding
28th Jan 20224:47 pmRNSTotal Voting Rights
24th Jan 20229:20 amRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSQ3 FY2022 Trading Update
4th Jan 202210:20 amRNSTotal Voting Rights
23rd Dec 20211:34 pmRNSDirector/PDMR Shareholding
17th Dec 202110:07 amRNSDirector/PDMR Shareholding
9th Dec 20219:11 amRNSChanges to Board and Committee Composition
1st Dec 20215:23 pmRNSTotal Voting Rights
30th Nov 20218:58 amRNSIssue of Equity
30th Nov 20217:00 amRNSHalf-year Report
29th Nov 20212:38 pmRNSHalf-year Report
29th Nov 20211:24 pmRNSHalf-year Report
26th Nov 20214:31 pmRNSHolding(s) in Company
25th Nov 20213:47 pmRNSRegulatory Approval
3rd Nov 20214:24 pmRNSDirector/PDMR Shareholding
26th Oct 202110:17 amRNSDirector/PDMR Shareholding
21st Oct 20214:43 pmRNSProposed secondary placing and loan of A shares
19th Oct 202112:05 pmRNSDirector/PDMR Shareholding
19th Oct 20217:00 amRNSQ2 Trading Update
8th Sep 20217:00 amRNSPublication of a Prospectus
7th Sep 20211:44 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.